Connie Lam (@connielam418), the official spokesperson of the first-ever “Beauty to Earn” beauty brand NFT series “Empower Beauties” created exclusively by Cellmax When the second stage rolls out, ...

DUBLIN--(BUSINESS WIRE)--The "Liquid Biopsy Market Industry Trends and Global Forecasts to 2035, by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-user, ...

CellMax Technologies AB, founded in 2001, is a privately owned company that develops and markets high efficiency base station antennas for mobile networks. CellMax headquarter and state of the art ...

Thank you for visiting "Code at Cellmax", our suite of cutting-edge software solutions developed exclusively for internal use at Cellmax Technologies AB. At Cellmax Technologies AB, we take pride in ...

Cellmax new twelve and eight-port platforms ,1207xx and 1209xx, further enhance CellMax world record efficiency levels and allows for more than 18dBi on the low band and up to 21.6dBi on the midband.

癌症筛查公司CellMax Life本周分享了其基于血液的结直肠癌检测方法FirstSight的多地点前瞻性研究的新数据。 这些结果虽然还没有公布，但数据明显是积极的，特别是关于对晚期腺瘤的诊断灵敏度，即转化为恶性结直肠癌的高风险的发育不良的前体结节。 由斯坦福 ...

NEW YORK – Cancer screening firm CellMax Life shared new data this week from a multisite prospective study of its blood-based colorectal cancer detection assay, FirstSight. The results, while ...

Data shows 92% sensitivity for colorectal cancer and 55% sensitivity for precancerous advanced adenomas at 91% specificity. Data to be presented at ASCO Gastrointestinal Cancers Symposium The data ...

A new high-gain antenna from CellMax offers extreme coverage to maximize spectrum usage. The new antenna (12086x) has 58% more gain on the two arrays ranging from 698-960 MHz offering 30% more ...

Reine’s long industry experience and track record building global business’ towards the telecom sector will help CellMax to meet the significantly increased demands for high performing antennas. The ...

FDA has closed out the summer with another batch of breakthrough device designations, including awards of regulatory privileges to products used in the treatment and detection of cancers. The ...